Bartholomew J. Votta

5.4k total citations
30 papers, 2.5k citations indexed

About

Bartholomew J. Votta is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bartholomew J. Votta has authored 30 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Immunology. Recurrent topics in Bartholomew J. Votta's work include Bone Metabolism and Diseases (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cell death mechanisms and regulation (4 papers). Bartholomew J. Votta is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cell death mechanisms and regulation (4 papers). Bartholomew J. Votta collaborates with scholars based in United States, United Kingdom and Canada. Bartholomew J. Votta's co-authors include Don E. Griswold, Sanjay Kumar, Jerry L. Adams, A M Badger, John C. Lee, Jeremy N. Bradbeer, David C. Underwood, Farshid Guilak, Wolfgang Liedtke and Maxine Gowen and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Annals of the New York Academy of Sciences.

In The Last Decade

Bartholomew J. Votta

30 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bartholomew J. Votta United States 19 1.4k 569 450 363 297 30 2.5k
Ehud Razin Israel 37 2.3k 1.6× 385 0.7× 2.1k 4.8× 319 0.9× 160 0.5× 116 4.4k
Lily Huang United States 27 2.2k 1.6× 533 0.9× 439 1.0× 219 0.6× 278 0.9× 62 3.7k
Xiang Lin China 24 826 0.6× 341 0.6× 552 1.2× 105 0.3× 210 0.7× 108 2.4k
Stephen A. Stimpson United States 27 1000 0.7× 263 0.5× 530 1.2× 317 0.9× 295 1.0× 40 2.4k
Shinji Naito Japan 23 1.5k 1.0× 638 1.1× 727 1.6× 90 0.2× 514 1.7× 60 3.5k
Alison M. Badger United States 24 1.1k 0.8× 524 0.9× 675 1.5× 702 1.9× 273 0.9× 64 2.8k
Jeffrey R. Weidner United States 18 934 0.6× 326 0.6× 604 1.3× 638 1.8× 439 1.5× 39 2.7k
Tomoh Matsumiya Japan 30 1.2k 0.9× 535 0.9× 1.4k 3.1× 266 0.7× 281 0.9× 126 3.0k
Marco van Eijk Netherlands 35 1.9k 1.3× 258 0.5× 1.4k 3.2× 118 0.3× 264 0.9× 60 4.0k
Jean‐Philippe Salier France 27 1.1k 0.8× 299 0.5× 420 0.9× 226 0.6× 282 0.9× 66 2.4k

Countries citing papers authored by Bartholomew J. Votta

Since Specialization
Citations

This map shows the geographic impact of Bartholomew J. Votta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bartholomew J. Votta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bartholomew J. Votta more than expected).

Fields of papers citing papers by Bartholomew J. Votta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bartholomew J. Votta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bartholomew J. Votta. The network helps show where Bartholomew J. Votta may publish in the future.

Co-authorship network of co-authors of Bartholomew J. Votta

This figure shows the co-authorship network connecting the top 25 collaborators of Bartholomew J. Votta. A scholar is included among the top collaborators of Bartholomew J. Votta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bartholomew J. Votta. Bartholomew J. Votta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ludbrook, Valerie J., David C. Budd, Debra Tompson, et al.. (2024). Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Dermatology and Therapy. 14(2). 489–504. 8 indexed citations
2.
Miah, Afjal H., Ian E. Smith, M.D. Rackham, et al.. (2021). Optimization of a Series of RIPK2 PROTACs. Journal of Medicinal Chemistry. 64(17). 12978–13003. 49 indexed citations
3.
Charnley, Adam K., M.A. Convery, Emma J. Jones, et al.. (2015). Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity. Bioorganic & Medicinal Chemistry. 23(21). 7000–7006. 24 indexed citations
4.
Irving, Aaron T., Hitomi Mimuro, Thomas A. Kufer, et al.. (2014). The Immune Receptor NOD1 and Kinase RIP2 Interact with Bacterial Peptidoglycan on Early Endosomes to Promote Autophagy and Inflammatory Signaling. Cell Host & Microbe. 15(5). 623–635. 198 indexed citations
5.
Clark, Robert B., Noriyuki Hatano, Colleen Kondo, et al.. (2010). Voltage-gated K+currents in mouse articular chondrocytes regulate membrane potential. Channels. 4(3). 179–191. 22 indexed citations
6.
Clark, Andrea L., Bartholomew J. Votta, Sanjay Kumar, Wolfgang Liedtke, & Farshid Guilak. (2010). Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: Age‐ and sex‐dependent progression of osteoarthritis in Trpv4‐deficient mice. Arthritis & Rheumatism. 62(10). 2973–2983. 152 indexed citations
7.
Leddy, Holly A., Bartholomew J. Votta, Sanjay Kumar, et al.. (2009). Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes. Arthritis & Rheumatism. 60(10). 3028–3037. 240 indexed citations
8.
Pritchard, Sophie, Bartholomew J. Votta, Sanjay Kumar, & Farshid Guilak. (2008). Interleukin-1 inhibits osmotically induced calcium signaling and volume regulation in articular chondrocytes. Osteoarthritis and Cartilage. 16(12). 1466–1473. 23 indexed citations
9.
10.
Patil, Ashok D., Alan J. Freyer, Lew Killmer, et al.. (2002). A New Dimeric Dihydrochalcone and a New Prenylated Flavone from the Bud Covers ofArtocarpusaltilis:  Potent Inhibitors of Cathepsin K. Journal of Natural Products. 65(4). 624–627. 53 indexed citations
11.
Kumar, Sanjay, Bartholomew J. Votta, David J. Rieman, et al.. (2001). IL‐1‐ and TNF‐induced bone resorption is mediated by p38 mitogen activated protein kinase*. Journal of Cellular Physiology. 187(3). 294–303. 89 indexed citations
12.
Lee, John C., Sanjay Kumar, Don E. Griswold, et al.. (2000). Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 47(2-3). 185–201. 386 indexed citations
13.
Votta, Bartholomew J., John R. White, Robert A. Dodds, et al.. (2000). CK?-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. Journal of Cellular Physiology. 183(2). 196–207. 61 indexed citations
14.
Kumar, Sanjay, Janice R. Connor, Robert A. Dodds, et al.. (1999). Identification and Cloning of a Connective Tissue Growth Factor-like cDNA from Human Osteoblasts Encoding a Novel Regulator of Osteoblast Functions. Journal of Biological Chemistry. 274(24). 17123–17131. 88 indexed citations
15.
Votta, Bartholomew J. & Donald R. Bertolini. (1994). Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro. Bone. 15(5). 533–538. 27 indexed citations
16.
Bertolini, Donald R., Bartholomew J. Votta, Sandra J. Hoffman, & Gideon Strassmann. (1994). Interleukin 6 production in fetal rat long bone cultures is correlated with PGE2 release and does not correlate with the extent of bone resorption. Cytokine. 6(4). 368–375. 17 indexed citations
17.
Badger, A M, Don E. Griswold, Damien J. Dunnington, et al.. (1993). Bicyclic Imidazoles as a Novel Class of Cytokine Biosynthesis Inhibitors. Annals of the New York Academy of Sciences. 696(1). 149–170. 125 indexed citations
18.
O’Sullivan, Brian, Seymour Mong, Bartholomew J. Votta, & Daniel V. Schidlow. (1992). Reduction of eicosanoid production by essential fatty acid depletion does not attenuate the inflammatory response induced by Pseudomonas aeruginosa pneumonia in rat lung. Prostaglandins Leukotrienes and Essential Fatty Acids. 46(3). 203–210. 1 indexed citations
19.
Mong, Seymour, Bartholomew J. Votta, Henry M. Sarau, et al.. (1990). 15-acetylthioxy-furodysinin lactone, isolated from a marine sponge , SP. is a potent agonist to human leukotriene B4 receptor. Prostaglandins. 39(1). 89–97. 6 indexed citations
20.
Griswold, Don E., et al.. (1988). Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. International Journal of Immunopharmacology. 10(7). 835–843. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026